Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950135-98-000918
Filing Date
1998-02-13
Accepted
1998-02-13 00:00:00
Documents
1
Group Members
ADVENT INTERNATIONAL CORP ET ALADVENT INTERNATIONAL CORPORATIONADVENT INTERNATIONAL INVESTORS II LIM. PART.ADVENT INTERNATIONAL LIMITED PARTNERSHIPADVENT PERFORMANCE MATERIALS LIMITED PARTNERSHIPGLOBAL PROVATE EQUITY II LIMITED PARTNERSHIPROVENT II LIMITE
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 ADVENT INTERNATIONAL CORPORATION "TRANSCEND" SC 13G 27158
  Complete submission text file 0000950135-98-000918.txt   29526
Mailing Address 101 FEDERAL STREET BOSTON MA 02110
Business Address 101 FEDERAL STREET BOSTON MA 02110 6179519400
ADVENT INTERNATIONAL CORP ET AL (Filed by) CIK: 0000939424 (see all company filings)

EIN.: 042840139 | State of Incorp.: DE | Fiscal Year End: 1231

Mailing Address 640 MEMORIAL DR 3W CAMBRIDGE MA 02139
Business Address 640 MEMORIAL DR 3W CAMBRIDGE MA 02139 6173741200
TRANSCEND THERAPEUTICS INC (Subject) CIK: 0001020910 (see all company filings)

EIN.: 043174575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-52371 | Film No.: 98538282
SIC: 2836 Biological Products, (No Diagnostic Substances)